Int J Radiat Oncol Biol Phys 2020 Nov 15
Stereotactic Ablative Radiotherapy for ≥T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK).
Related Questions
Data for SBRT for RCC is promising but there is increasing literature on microwave ablation, radio frequency, and cryoablation. Are there any distinct...
New comment by Radiation Oncologist at Rwj Saint Barnabas Medical Center ( March 14, 2024)
*One (1%) patient developed an acute grade 4 duodenal ulcer and late grade 4 gastritis in the IROCK analysis of SBRT. Siva et al., PMID 36400098
Recently published FAST...
If a patient is considered high risk for surgery, with another primary cancer (HCC) and has an incidental renal finding that is highly suspicious for ...
New answer by Radiation Oncologist at McMaster University School of Medicine (November 21, 2024)
Interesting question. In the IROCK metaanalysis, 83% of the patients had pathological confirmation. So not everyone requires a biopsy although it is recommended. In cases like...